Absci: Downgrade To 'Hold' As ABS-101 On Back Burner And Pivot To ABS-201
Source: SeekingAlpha
2026-03-25 14:48:04 ET
The last time I spoke about Absci Corporation ( ABSI ), it was in a Seeking Alpha article entitled " Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile. " The hope here was that upon the release of data, the company could show a competing half-life when it came to its TL1A candidate ABS-101 in the targeting of patients with irritable bowel syndrome [IBS]....
Read the full article on Seeking Alpha
For further details see:
Absci: Downgrade To 'Hold' As ABS-101 On Back Burner And Pivot To ABS-201
Absci Corporation
NASDAQ: ABSI
ABSI Trading
22.16% G/L:
$7.085 Last:
5,240,234 Volume:
$5.99 Open:
ABSI Latest News
May 07, 2026 04:05:00 pm
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
April 23, 2026 04:05:00 pm
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
ABSI Stock Data
$396,980,842
134,597,557
0.04%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
Vancouver
